67 related articles for article (PubMed ID: 11699397)
21. Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents.
Tadmor T; Levy I
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680290
[TBL] [Abstract][Full Text] [Related]
22. Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
Herrera AF; Ahn KW; Litovich C; Chen Y; Assal A; Bashir Q; Bayer RL; Coleman M; DeFilipp Z; Farhadfar N; Greenwood M; Hahn T; Horwitz M; Jacobson C; Jaglowski S; Lachance S; Langston A; Mattar B; Maziarz RT; McGuirk J; Mian MAH; Nathan S; Phillips A; Rakszawski K; Sengeloev H; Shenoy S; Stuart R; Sauter CS; Kharfan-Dabaja MA; Hamadani M
Blood Adv; 2021 Sep; 5(18):3528-3539. PubMed ID: 34496026
[TBL] [Abstract][Full Text] [Related]
23. Richter Syndrome.
Condoluci A; Rossi D
Curr Oncol Rep; 2021 Feb; 23(3):26. PubMed ID: 33580422
[TBL] [Abstract][Full Text] [Related]
24. Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration.
Stephens DM; Boucher K; Kander E; Parikh SA; Parry EM; Shadman M; Pagel JM; Cooperrider J; Rhodes J; Mato A; Winter A; Hill B; Gaballa S; Danilov A; Phillips T; Brander DM; Smith SM; Davids M; Rogers K; Glenn MJ; Byrd JC
Haematologica; 2021 Nov; 106(11):2845-2852. PubMed ID: 33054118
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis.
Aulakh S; Reljic T; Yassine F; Ayala E; Chavez JC; Chanan-Khan A; Pinilla-Ibarz J; Kumar A; Kharfan-Dabaja MA
Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):33-40. PubMed ID: 32473105
[TBL] [Abstract][Full Text] [Related]
26. Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.
Al-Sawaf O; Robrecht S; Bahlo J; Fink AM; Cramer P; V Tresckow J; Lange E; Kiehl M; Dreyling M; Ritgen M; Dürig J; Tausch E; Schneider C; Stilgenbauer S; Wendtner CM; Fischer K; Goede ; Hallek M; Eichhorst B
Leukemia; 2021 Jan; 35(1):169-176. PubMed ID: 32203141
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center.
Wang Y; Tschautscher MA; Rabe KG; Call TG; Leis JF; Kenderian SS; Kay NE; Muchtar E; Van Dyke DL; Koehler AB; Schwager SM; Slager SL; Parikh SA; Ding W
Haematologica; 2020 Mar; 105(3):765-773. PubMed ID: 31197071
[TBL] [Abstract][Full Text] [Related]
28. The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.
Xia L; Wang Y; Li T; Hu X; Chen Q; Liu L; Jiang B; Li C; Wang H; Wang S; Yang G; Bao Y
Cancer Med; 2019 Jun; 8(6):2930-2941. PubMed ID: 31050207
[TBL] [Abstract][Full Text] [Related]
29. The involvement of microRNA in the pathogenesis of Richter syndrome.
Van Roosbroeck K; Bayraktar R; Calin S; Bloehdorn J; Dragomir MP; Okubo K; Bertilaccio MTS; Zupo S; You MJ; Gaidano G; Rossi D; Chen SS; Chiorazzi N; Thompson PA; Ferrajoli A; Bertoni F; Stilgenbauer S; Keating MJ; Calin GA
Haematologica; 2019 May; 104(5):1004-1015. PubMed ID: 30409799
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Richter's Syndrome.
Condoluci A; Rossi D
Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
[TBL] [Abstract][Full Text] [Related]
31. Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.
Master S; Leary C; Takalkar A; Coltelingam J; Mansour R; Mills GM; Koshy N
Case Rep Oncol; 2017; 10(2):534-541. PubMed ID: 28690529
[TBL] [Abstract][Full Text] [Related]
32. Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.
Thyagarajan B; Alagusundaramoorthy SS; Shah L; Agrawal A
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27288204
[TBL] [Abstract][Full Text] [Related]
33. Richter Syndrome in Chronic Lymphocytic Leukemia.
Vitale C; Ferrajoli A
Curr Hematol Malig Rep; 2016 Feb; 11(1):43-51. PubMed ID: 26830086
[TBL] [Abstract][Full Text] [Related]
34. Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.
Eyre TA; Clifford R; Roberts C; Boyle L; Francis A; Schuh A; Dutton SJ
BMC Cancer; 2015 Feb; 15():52. PubMed ID: 25775024
[TBL] [Abstract][Full Text] [Related]
35. Ibrutinib has some activity in Richter's syndrome.
Giri S; Hahn A; Yaghmour G; Martin MG
Blood Cancer J; 2015 Jan; 5(1):e277. PubMed ID: 25635530
[No Abstract] [Full Text] [Related]
36. How we treat Richter syndrome.
Parikh SA; Kay NE; Shanafelt TD
Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
[TBL] [Abstract][Full Text] [Related]
37. Richter's transformation in chronic lymphocytic leukemia.
Tsimberidou AM; Keating MJ; Wierda WG
Curr Hematol Malig Rep; 2007 Oct; 2(4):265-71. PubMed ID: 20425379
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in the diagnosis and therapy of Richter's syndrome.
Swords R; Bruzzi J; Giles F
Med Oncol; 2007; 24(1):17-32. PubMed ID: 17673808
[TBL] [Abstract][Full Text] [Related]
39. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.
Dabaja BS; O'Brien SM; Kantarjian HM; Cortes JE; Thomas DA; Albitar M; Schlette ES; Faderl S; Sarris A; Keating MJ; Giles FJ
Leuk Lymphoma; 2001 Jul; 42(3):329-37. PubMed ID: 11699397
[TBL] [Abstract][Full Text] [Related]
40. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Tsimberidou AM; Kantarjian HM; Cortes J; Thomas DA; Faderl S; Garcia-Manero G; Verstovsek S; Ferrajoli A; Wierda W; Alvarado Y; O'Brien SM; Albitar M; Keating MJ; Giles FJ
Cancer; 2003 Apr; 97(7):1711-20. PubMed ID: 12655528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
